Ticker Hub
AQST — AI Analysis & Sentiment
3 recent AI-generated analyses for AQST. Sentiment and confidence insights updated continuously.
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
Aquestive's debt refinancing significantly improves its financial flexibility, providing crucial capital for the potential launch of Anaphylm and m...
May 12, 2026Aquestive Therapeutics to Present New Clinical Data on Anaphylm™ (dibutepinephrine) Sublingual Film at the 2026 AAAAI Annual Meeting
Aquestive Therapeutics is poised for a significant catalyst with the presentation of positive clinical data for its Anaphylm™ product, which has th...
Feb 20, 2026Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Aquestive's appointment of Dr. Greenhawt as Chief Medical Officer strengthens its team for the critical Anaphylm NDA resubmission. This increases t...
Feb 18, 2026